LEARN CURRENT PRACTICES THAT DEFINE AN OBJECTIONAB 2015 - Objectionable Microorganisms: Considering the Risk

Website http://bit.ly/1GyzAJJ | Edit Freely

Category Biotech;

Deadline: March 03, 2015 | Date: March 03, 2015

Venue/Country: Palo Alto, U.S.A

Updated: 2015-02-27 13:21:37 (GMT+9)

Call For Papers - CFP

Why Should You Attend:

Due to increased scrutiny by the FDA and other regulatory agencies, companies must now determine how to reduce the risk if they find objectionable microorganisms. This webinar will provide an expert's insight into reducing this risk.

Who Will Benefit:

All FDA regulated companies will benefit from this webinar - pharmaceutical, biotech, medical device companies and laboratories.

Quality system auditors

QA directors and managers

Information technology managers and personnel

Microbiology analysts and technicians

Consultants

Instructor Profile:

Henry Urbach is a founder of GMP Training, Development and Consulting (GMP TDC) LLC, a New York-based consulting organization serving life sciences industries. He has over 20 years of life sciences experience having held positions of increased responsibility in training, QA, and QC microbiology.

Use coupon code 232082 and get 10% off on registration.